Hospital Universitario de Basurto-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2021

  1. Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia (BMC Pulmonary Medicine, (2020), 20, 1, (261), 10.1186/s12890-020-01293-6)

    BMC Pulmonary Medicine

2020

  1. Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia

    BMC Pulmonary Medicine, Vol. 20, Núm. 1

2016

  1. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

  2. Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial

    JAMA Internal Medicine, Vol. 176, Núm. 9, pp. 1257-1265

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

  2. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation

    Respiration, Vol. 88, Núm. 4, pp. 298-306

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2011

  1. Explicit criteria for hospital admission in exacerbations of chronic obstructive pulmonary disease

    International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 5, pp. 680-686